Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Urine leukemia inhibitory factor predicts kidney function recovery in patients with acute interstitial nephritis
Long Qian, Megan L. Baker, Laura Aponte Becerra, Cathleen Liang, Emma Koval, Kyra Shelton, Daris Javed, Gilbert Moeckel, Deepika Kumar, Avi Z. Rosenberg, Michael Kuperman, Tinyi Chu, Wassim Obeid, Xuefei Tian, Chirag R. Parikh, Leyuan Xu, Jonathan Barasch, Shuta Ishibe, Lloyd G. Cantley, Dennis G. Moledina
Long Qian, Megan L. Baker, Laura Aponte Becerra, Cathleen Liang, Emma Koval, Kyra Shelton, Daris Javed, Gilbert Moeckel, Deepika Kumar, Avi Z. Rosenberg, Michael Kuperman, Tinyi Chu, Wassim Obeid, Xuefei Tian, Chirag R. Parikh, Leyuan Xu, Jonathan Barasch, Shuta Ishibe, Lloyd G. Cantley, Dennis G. Moledina
View: Text | PDF
Research Letter Clinical Research Nephrology

Urine leukemia inhibitory factor predicts kidney function recovery in patients with acute interstitial nephritis

  • Text
  • PDF
Abstract

Authors

Long Qian, Megan L. Baker, Laura Aponte Becerra, Cathleen Liang, Emma Koval, Kyra Shelton, Daris Javed, Gilbert Moeckel, Deepika Kumar, Avi Z. Rosenberg, Michael Kuperman, Tinyi Chu, Wassim Obeid, Xuefei Tian, Chirag R. Parikh, Leyuan Xu, Jonathan Barasch, Shuta Ishibe, Lloyd G. Cantley, Dennis G. Moledina

×

Figure 1

Urinary LIF is associated with recovery after AIN.

Options: View larger image (or click on image) Download as PowerPoint
Urinary LIF is associated with recovery after AIN.
(A) Volcano plot of p...
(A) Volcano plot of proteins associated with recovery, controlled for age, sex, and urine creatinine (2-tailed t test with multiple testing correction). (B and C) Predictive models for recovery in AIN in test (B) and validation (C) cohorts (ROC analysis). (D) LIF measured by immunoassay. (E) Cells expressing LIF. (F) Factors downstream of LIFR signaling, including SOCS3, have higher expression in neighbors of LIF+ cells compared with nonneighbors. (G) Among injured proximal tubule cells, SOCS3 expression is higher when closer to LIF+ cells (Wilcoxon rank-sum test). (H and I) Immunofluorescence quantification of percentage of p-STAT3+ nuclei (within tubular and interstitial compartments) and SOCS3 expression. Fluorescence intensity in arbitrary units, mean ± SEM (2-way ANOVA [H] and 1-way ANOVA [I]). Two nephrectomy healthy controls (regions of interest [ROI] = 15), 2 AIN low-urine-LIF patients with nonrecovery (ROI = 15), and 3 AIN high-urine-LIF patients with recovery (ROI = 30).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts